Together, we find that many systemic clinical features — including cytokine production in MAS, specifically — require macrophage responsiveness to IFN-γ, while others, including IL-6 induction and lymphopenia, were unaltered. The gene discussed is IL6; the disease is macrophage activation syndrome.